Flecainide acetate and Rash macular - a phase IV clinical study of FDA data

Summary:

Rash macular is reported as a side effect among people who take Flecainide acetate (flecainide acetate), especially for people who are male, 60+ old, have been taking the drug for 2 - 5 years also take Aspirin, and have Osteoporosis.

The phase IV clinical study analyzes which people have Rash macular when taking Flecainide acetate. It is created by eHealthMe based on reports of 6,177 people who have side effects when taking Flecainide acetate from the FDA, and is updated regularly.

What is Flecainide acetate?

Flecainide acetate has active ingredients of flecainide acetate. It is often used in atrial fibrillation/flutter. eHealthMe is studying from 7,176 Flecainide acetate users. Check the latest studies of Flecainide acetate.

What is Rash macular?

Rash macular (small, flat red spots) is found to be associated with 1,373 drugs and 1,510 conditions by eHealthMe. Check the latest studies of Rash macular.

On Jul, 19, 2026

6,177 people reported to have side effects when taking Flecainide acetate.
Among them, 14 people (0.23%) have Rash macular.

Could Flecainide acetate cause Rash macular?

Among these 14 people:

How long have people been on Flecainide acetate when they have Rash macular? *

What is the gender of people who have Rash macular when taking Flecainide acetate? *

female: 42.86 %
male: 57.14 %

What is the age of people who have Rash macular when taking Flecainide acetate? *

What are other drugs people take besides Flecainide acetate? *

What are other side effects people have besides Rash macular? *

Back Pain: 6 people, 42.86%
Fatigue (feeling of tiredness): 5 people, 35.71%
Muscle Spasms (muscle contraction): 3 people, 21.43%
Movement Disorder (neurological syndromes where they may be excess of movement or a paucity of movement that is not connected to weakness): 3 people, 21.43%
Motion Sickness (travel sickness): 3 people, 21.43%
Limb Asymmetry (consistent task discrepancy between the two lower limbs): 3 people, 21.43%
Weakness: 3 people, 21.43%
Pain: 3 people, 21.43%
Pain In Extremity: 3 people, 21.43%
Joint Pain: 3 people, 21.43%

What are the existing conditions these people have? *

Osteoporosis (bones weak and more likely to break): 4 people, 28.57%
High Blood Pressure: 3 people, 21.43%
Metastases To Liver (cancer spreads to liver): 2 people, 14.29%
Malignant Splenic Neoplasm (cancer tumour of spleen): 2 people, 14.29%
Type 2 Diabetes: 1 person, 7.14%
Stroke (sudden death of a portion of the brain cells due to a lack of oxygen): 1 person, 7.14%
Pneumonia Bacterial (pneumonia associated with bacterial infection): 1 person, 7.14%
Metastasis (spreadable cancer to other organ from origin): 1 person, 7.14%
Lymphoma (cancer that begins in immune system cells): 1 person, 7.14%
Diabetes: 1 person, 7.14%

* Approximation only. Some reports may have incomplete information.

Do you take Flecainide acetate and have Rash macular?

- Check whether Rash macular is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Flecainide acetate:

Flecainide acetate (7,176 reports)

Rash macular treatments and more:

Rash macular (36,440 reports)

Browse all side effects of Flecainide acetate:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Rash macular:

Rash macular (1,373 drugs)

Browse all the conditions that are associated with Rash macular:

Rash macular (1,510 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on flecainide acetate (the active ingredients of Flecainide acetate) and Flecainide acetate (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.